蓝丰生化(002513) - 2017 Q1 - 季度财报

Financial Performance - Revenue for Q1 2017 was CNY 385,878,541.86, an increase of 14.91% compared to CNY 335,810,423.21 in the same period last year[8] - Net profit attributable to shareholders decreased by 35.08% to CNY 20,588,356.08 from CNY 31,711,410.82 year-on-year[8] - Net profit excluding non-recurring items was CNY 21,127,701.01, down 19.86% from CNY 26,364,366.04 in the previous year[8] - Basic and diluted earnings per share both decreased by 33.33% to CNY 0.06 from CNY 0.09[8] - The company expects net profit attributable to shareholders for the first half of 2017 to range from CNY 55 million to CNY 70 million, representing a year-on-year change of -14.14% to 9.28%[20] Cash Flow and Assets - Net cash flow from operating activities was negative at CNY -47,969,935.59, a decline of 157.29% compared to CNY 83,738,222.35 in the same period last year[8] - Total assets at the end of the reporting period were CNY 4,080,864,380.81, a slight increase of 0.76% from CNY 4,050,146,095.00 at the end of the previous year[8] - Net assets attributable to shareholders increased by 0.80% to CNY 2,531,064,724.80 from CNY 2,510,887,599.31[8] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,129[11] - The largest shareholder, Jiangsu Suhua Group Co., Ltd., held 19.38% of the shares, totaling 65,910,240 shares[11] Receivables and Liabilities - Accounts receivable increased by 35.3% compared to the beginning of the year, primarily due to increased sales revenue[15] - Prepaid accounts increased by 61.42% compared to the beginning of the year, mainly due to increased advance payments for purchases[15] - Other receivables increased by 68.25% compared to the beginning of the year, primarily due to increased payments for unbilled expenses[15] - Other current liabilities increased by 115.91% compared to the beginning of the year, mainly due to unpaid electricity invoices[15] Impairment and Expenses - Asset impairment losses increased by 60.84% year-on-year, mainly due to an increase in accounts receivable compared to the same period last year[15] - Cash paid for purchasing goods and services increased by 75.17% year-on-year, primarily due to a decrease in bill settlements in the previous year[15] Corporate Actions - The company plans to issue shares to acquire 100% equity of a target asset in the pharmaceutical manufacturing industry[17] - The company’s stock was delisted risk warning lifted on April 7, 2017, with the stock name changed back to "蓝丰生化" and the daily price limit increased to 10%[17] Government Support - The company received government subsidies amounting to CNY 544,700.00 during the reporting period[9] Previous Year Performance - Operating income for 2016 was approximately CNY 1.46 billion, with a net profit attributable to shareholders of CNY 107.18 million[16]